+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Kaempferol 3,7,4'-trimethyl ether

SBP03000
15486-34-7
98%
Biopurify
1. Kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome. 2. Kaempferol exerts a potent inhibitory effect on in vitro bone resorption. 3. Kaempferol has anti-inflammatory action, can prevent and treat inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis. 4. Kaempferol has therapeutic potential for the prevention and treatment of thrombovascular diseases, can enhance relaxations caused by endothelium-derived and exogenous NO as well as those due to endothelium-dependent hyperpolarization. 5. Kaempferol can inhibit cancer cell invasion through blocking the PKCδ/MAPK/AP-1 cascade and subsequent MMP-9 expression and its activity, may act as a therapeutic potential candidate for cancer metastasis. 6. Kaempferol is an autophagic enhancer, has a more general protection in Parkinson's disease, can mediate antiapoptotic and antioxidant effects is the enhancement of mitochondrial turnover by autophagy.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP03000-10mg 10mg
SBP03000-20mg 20mg
SBP03000-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

AMPK MAPK1 TNF PPARG NFKB1 NRF2 GPX1 HMOX1 SOD2 PRKN PINK1
AMPK PRKCD MAPK1 TNF PPARG JUN MMP9 NFKB1 HMOX1
AMPK MAPK1 TNF PPARG SREBF1 NFKB1 NR1H2 CAT GPX1 HMOX1
NRF2 CAT GPX1 HMOX1 SOD2
PRKCD MAPK1 JUN MMP9

Product drug property prediction parameters

  • 83.6200

  • 3.3100

  • Low

  • Unknown

  • Unknown

  • Unknown

  • Unknown

  • Unknown

  • Unknown